centre hospitalier lyon sud ( Site 0497)

Pierre-Bénite, Rhone 69310

1 studies enrolling now · 1 studies all time

What they study most

Castration-Resistant Prostatic Cancer, Metastasis

Studies at this site

• A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) — Recruiting now